Several inflammatory markers, such as modified Glasgow Prognostic Score (mGPS), C-reactive protein (CRP), and the combination of neutrophil, lymphocyte, monocyte count plays a key role in prognosis in RCC [5–7]. This evidence concerns the gene CRP and renal cell carcinoma.